NAYA Biosciences
Daniel Teper is currently serving as the Chairman and CEO of NAYA Biosciences and as Chairman of CYTOVIA Therapeutics, Inc. In addition, Daniel is a Member of The Supervisory Board at Crossject. With a background in Strategy Consulting and Corporate Development in Life Sciences, Daniel has extensive experience in leadership positions within the healthcare industry.
This person is not in any teams
NAYA Biosciences
NAYA Biosciences is building a group of companies leveraging the next generation of biotechnologies to increase patient access to life-transforming treatments in oncology, fertility, and regenerative medicine. Our unique capabilities in biology, cell and gene therapy, and artificial intelligence provide a synergistic platform for the accelerated clinical development and commercialization of these breakthrough treatments.